These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 544290)

  • 21. [In vitro inhibitory effect of phenylbutazone on the hemolytic activity of complement in guinea pigs].
    Lang JM; Hainaut J
    Agressologie; 1972; 13(2):117-20. PubMed ID: 5078837
    [No Abstract]   [Full Text] [Related]  

  • 22. Activation of the first component of complement evidence for an internal activation step.
    Loos M; Borsos T; Rapp HJ
    J Immunol; 1972 Mar; 108(3):683-8. PubMed ID: 5011751
    [No Abstract]   [Full Text] [Related]  

  • 23. Capillary transport of immunoglobulins and complement proteins to the interstitial fluid and lymph.
    Olszewski WL; Engeset A
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):57-65. PubMed ID: 749810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific inactivation of the fourth complement component. II. In vitro studies.
    Garces MC; Jensen JA; Iglesias E
    Infect Immun; 1971 Oct; 4(4):446-51. PubMed ID: 5154891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The third component of complement and complement receptors (author's transl)].
    Okuda T; Tachibana T
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(9):657-67. PubMed ID: 4215099
    [No Abstract]   [Full Text] [Related]  

  • 26. Anticomplementary activity in unaggregated "purified" macroglobulin paraproteins.
    Glovsky MM; Fudenberg HH
    Immunochemistry; 1971 Feb; 8(2):129-40. PubMed ID: 4102100
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemolytic activity of leukemic sera: the role of complement and sucrose.
    Berchtold PE; Spaeth PJ; Haeberli A; Straub PW
    J Lab Clin Med; 1986 Jun; 107(6):544-50. PubMed ID: 3086472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular structure alteration of IgG increased anticomplementary activity of intravenous immunoglobulin.
    Zang XX; Sun Y; Shen F; Wang D; Zhou L; Wang J; Kung E
    Zhongguo Yao Li Xue Bao; 1995 Sep; 16(5):415-9. PubMed ID: 8701757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement.
    Gaither TA; Alling DW; Frank MM
    J Immunol; 1974 Aug; 113(2):574-83. PubMed ID: 4210883
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunochemical quantitaion of the third component of guinea pig complement in fluid phase and bound to cell surfaces.
    Ohanian SH; Borsos T
    J Immunol; 1975 Jan; 114(1 Pt 2):326-30. PubMed ID: 1167878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum reactions. An analysis of commercial antivenoms and the possible role of anticomplementary activity in de-novo reactions to antivenoms and antitoxins.
    Sutherland SK
    Med J Aust; 1977 Apr; 1(17):613-5. PubMed ID: 327229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A simplified method for the assessment of C1 esterase inhibitor function].
    Deguchi M; Takemura S; Ueda M; Kasamatsu Y; Yanagida K; Fukuda W; Okamoto M; Onodera H; Sugino S; Kondo M
    Ryumachi; 1990 Jun; 30(3):166-71. PubMed ID: 2244251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 35. C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.
    Ruddy S; Austen KF
    J Immunol; 1971 Sep; 107(3):742-50. PubMed ID: 4999095
    [No Abstract]   [Full Text] [Related]  

  • 36. Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. 3. The hemolytic efficiency of human and guinea pig C2 and C4.
    Opferkuch W; Rapp HJ; Colten HR; Borsos T
    J Immunol; 1971 Apr; 106(4):927-31. PubMed ID: 4995006
    [No Abstract]   [Full Text] [Related]  

  • 37. Complement titration by rectilinear attenuance and attempts at its automatization.
    Sato PS; Yoshida TO; Fukusima Y; Ono N; Yoshida K; Ito Y
    Immunology; 1969 Dec; 17(6):831-45. PubMed ID: 5386637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement: optimal reaction conditions for guinea pig C4.
    Linscott WD
    J Immunol; 1973 Jul; 111(1):189-99. PubMed ID: 4197333
    [No Abstract]   [Full Text] [Related]  

  • 39. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.
    Ballow M; Cochrane CG
    J Immunol; 1969 Nov; 103(5):944-52. PubMed ID: 4981797
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies of complement-mediated membrane damage: the influence of erythrocyte storage on susceptibility to cytolysis.
    Gaither TA; Frank MM
    J Immunol; 1973 Feb; 110(2):482-9. PubMed ID: 4684035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.